Ausgabe 3/2006
Inhalt (12 Artikel)
Interferon-α plus capecitabine and thalidomide in patients with metastatic renal cell carcinoma: A pilot study
Robert J. Amato, Anish Rawat
Pre-irradiation 9-Amino [20s] camptothecin (9-AC) in patients with newly diagnosed glioblastoma multiforme
Daniel Farray, Manmeet S. Ahluwalia, Josette Snyder, Gene H. Barnett, Bruce H. Cohen, John H. Suh, David M. Peereboom
Suppression of primary breast, colon, gastric and bladder cancers cell growth in vitro by CKBM, a natural product
Wei Zhang, Edgar S. L. Liu, Jun Fu, Hai-Mei Tian, Ying-Jye Wu, Shiu-Fun Pang
Flutamide in unresectable pancreatic adenocarcinoma: A randomized, double-blind, placebo-controlled trial
Sanjay Singh Negi, Anil Agarwal, Adarsh Chaudhary
Cytotoxicity of sphingoid marine compound analogs in mono- and multilayered solid tumor cell cultures
José M. Padrón, Godefridus J. Peters
Phase I and pharmacokinetic study of docetaxel, irinotecan, and celecoxib in patients with advanced non-small cell lung cancer
Athanassios Argiris, Victoria Kut, Lynn Luong, Michael J. Avram
A Phase I/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited-stage small cell lung cancer
Patrapim Sunpaweravong, Lyn Magree, Rachel Rabinovitch, Paul Bunn, Karen Kelly
Phase I study of Vinflunine administered as a 10-minute infusion on days 1 and 8 every 3 weeks
Peter Johnson, Thomas Geldart, Pierre Fumoleau, Marie-Claire Pinel, Laurent Nguyen, Ian Judson
Phase I trial of oral talactoferrin alfa in refractory solid tumors
Teresa G. Hayes, Gerald F. Falchook, Gauri R. Varadhachary, Dori P. Smith, Lisa D. Davis, Hari M. Dhingra, Benjamin P. Hayes, Atul Varadhachary
Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: Results of a prospective randomized phase II study
Emilio Esteban, Joaquin Fra, Yolanda Fernández, Norberto Corral, José M. Vieitez, Isabel Palacio, José L. de Sande, José L. Fernández, Isabel Muñiz, Noemi Villanueva, Enrique Estrada, Beatriz Mareque, Esther Uña, José M. Buesa, Angel J. Lacave
An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcoma
J. T. Hartmann, K. Oechsle, J. Huober, A. Jakob, M. Azemar, M. Horger, L. Kanz, C. Bokemeyer
Phase II study of interferon-alpha and doxycycline for advanced renal cell carcinoma
Michael Huie, Kurt Oettel, Lynn Van Ummersen, Kyung Mann Kim, Yulin Zhang, Mary Jane Staab, Dottie Horvath, Rebecca Marnocha, Jeff Douglas, Amy Drezen, Dona Alberti, George Wilding